KARPAS 620 Human Plasma Cell Leukaemia cell line

KARPAS 620 Human Plasma Cell Leukemia cell line useful in oncology research.
Technology No. CL14

KARPAS 620 Human Plasma Cell Leukemia cell line useful in oncology research, developed at the University of Cambridge.

Publications:

Nacheva et al. (1990). Br J Haematol 74, 70–76

Drexler and Matsuo (2000). Leuk Res 24, 681–703



  • swap_vertical_circlecloud_downloadSupporting documents (1)
    Product brochure
    KARPAS 620 Human Plasma Cell Leukaemia cell line.pdf
Questions about this technology?

Sign up to our newsletter

If you would like to keep up to date with the latest opportunities, please sign up to our newsletter.